Esperion Therapeutics reported $30.38M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amarin AMRN:US 90.65M 1.72M
Amgen AMGN:US $ 1.23B 197M
Biogen BIIB:US $ 634.9M 153M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Cytokinetics CYTK:US $ 33.07M 736K
Daiichi Sankyo 4568:JP 104.74B 14.78B
Eli Lilly And LLY:US $ 1.56B 34.1M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
Geron GERN:US $ 6.7M 1.17M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Intra Cellular Therapies ITCI:US $ 75.46M 4.22M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Merk MRK:US $ 2.3B 518M
Minerva Neurosciences NERV:US $ 3.03M 398.63K
Moderna Inc MRNA:US 268M 67M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
United Therapeutics UTHR:US $ 79M 47.9M
Vanda Pharmaceuticals VNDA:US $ 40.85M 7.4M